Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Triptorelin, ATC L02AE04 für die Zeit 01.09.2024 - 31.08.2026
Track this recordFree account — get alerted when a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- axicorp Pharma B.V., CC Pharma GmbH, EMRA-MED Arzneimittel GmbH, EurimPharm Arzneimittel GmbH, Ipsen Pharma GmbH, kohlpharma GmbH, Orifarm GmbH, Originalis B.V.
- Contract value
- no value published
- Bids received
- 8
- Published
- 23 Sept 2026
- Awarded
- 1 Sept 2024
- Contract start
- 1 Sept 2024
- Contract end
- 2 Sept 2025estimated
- Region
- Hamburg